Clinical Trials
50 trialsNelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery
M.D. Anderson Cancer Center
PIERCE
AGO Research GmbH
Reiki-Brachy
University of Utah
DOVE
Yonsei University
DP-04
AstraZeneca
DaVulvaRec
University of Aarhus
Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
Ohio State University Comprehensive Cancer Center
ANTARES
Instituto do Cancer do Estado de São Paulo
IGNITE-V
Hamilton Health Sciences Corporation
MITO VULVA-01
National Cancer Institute, Naples
(CLOCS-2)
Imperial College London
Electrochemotherapy for Recurrent Vulvar Cancer
Institute of Oncology Ljubljana
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Rutgers, The State University of New Jersey
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Rutgers, The State University of New Jersey
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Sichuan Enray Pharmaceutical Sciences Company
NODE
Queensland Centre for Gynaecological Cancer
Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
University Hospital Tuebingen
3D Printed Custom Applicators for HDR BT (DISCO)
Royal North Shore Hospital
SCANDARE
Institut Curie
STRIVE
British Columbia Cancer Agency
DOSTCONICG
Cukurova University
AKIR001
Karolinska University Hospital
Image-Guided Gynecologic Brachytherapy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
Dana-Farber Cancer Institute
Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
Emory University
RELAY
Dana-Farber Cancer Institute
CYCLOPS
CNAO National Center of Oncological Hadrontherapy
Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors
Yuhan Corporation
START-001
Marengo Therapeutics, Inc.
ASQ-GYO
Barbara Ann Karmanos Cancer Institute
RHINOCERUS
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Vulvar-AIN
Sunnybrook Health Sciences Centre
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
Northwestern University
AK104 for Recurrent or Metastatic Vulvar Cancer
Akeso
NYSCF Scientific Discovery Biobank
New York Stem Cell Foundation Research Institute
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Northwestern University
AMethysT
Assistance Publique - Hôpitaux de Paris
A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer
Zhejiang Cancer Hospital
HPV-VIM
Baylor College of Medicine
SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
The Affiliated Hospital of Qingdao University
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Shanghai Bovax Biotechnology Co., Ltd.
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years
Shanghai Bovax Biotechnology Co., Ltd.
HRYZ-T101 Injection for HPV18 Positive Solid Tumor
HRYZ Biotech Co.
SENTIVUC II
Rigshospitalet, Denmark
SENTIVUC
Rigshospitalet, Denmark
Quality of Life in Patients Undergone Vulvar Reconstruction After Vulvar Cancer Resection (3233)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
POPCORN
Centro di Riferimento Oncologico - Aviano
GROINSS-VIII
University Medical Center Groningen
Elechtra
IRCCS Azienda Ospedaliero-Universitaria di Bologna
RetroBT
Zhejiang Cancer Hospital